| Literature DB >> 16475977 |
Eliana P Araujo1, José Barreto Carvalheira, Licio A Velloso.
Abstract
Several growth-promoting signaling pathways have tight molecular connections with metabolic-related signal transduction systems. By controlling these pathways, cancer cells gain autonomy over energy-acquiring systems and, thus, expand their potential for proliferation. Here, we discuss the use of drug and antisense oligonucleotide approaches to inhibit metabolic pathways in cancer cells and their potential use in the therapeutics of cancer.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16475977 DOI: 10.2174/156800906775471734
Source DB: PubMed Journal: Curr Cancer Drug Targets ISSN: 1568-0096 Impact factor: 3.428